lorillard

The earnings crunch is in full swing this this week. Quarterly results are due from the likes of Caterpillar (NYSE: CAT), Exxon Mobil (NYSE: XOM), Procter & Gamble (NYSE: PG) and United Parcel Service (NYSE: UPS), from which analysts expect to see year-over-year earnings growth, as well as...

Citi is out with its report today on Lorillard (NYSE: LO), reiterating Buy. In a note to clients, Citi writes, "We remain encouraged by LO's healthy market share trends, as well as the company's positive price/mix and strong EBIT growth. In addition, today's news highlights the fact that pricing...

Bank of America reports that it learned (and confirmed) Thursday that Lorillard, Inc. (NYSE: LO) announced a list price increase on most of its cigarette brands. “Effective July 1, the wholesale price of Newport (menthol) will rise by $2.50 per 1000 cigarettes, or 50c per carton or 5c per pack,”...

Deutsche Bank made a number of updates in a research report published today. Flowers Foods (NYSE: FLO) had its rating reinstated at Hold. At the same time, its price target was reduced from $25 to $20. On Monday, Flowers added 0.25% to its value to end the day at $21.74. Medicis Pharmaceutical (...

Bank of America provided color on the tobacco industry. In a research report published today, Bank of America commented on the Master Settlement Agreement payments. In the report, Bank of America states, "According to the Wall Street Journal, major cigarette manufacturers, including Altria,...

Morgan Stanley reiterated its Equal-weight rating on Lorillard (NYSE: LO). In a research report published today, Morgan Stanley stressed that Lorillard's near-term risk-reward remains relatively unattractive. In the report, Morgan Stanley named the reasons as, "First, we have received little...

Morgan Stanley downgraded its rating on Lorillard (NYSE: LO) from Overweight to Equal-weight. In a research report published today, Morgan Stanley states, "Downgrading LO to Equal-weight for two reasons: (i) The stock is up ~37% since the submission of the TPSAC report in March (and only ~8%...

Morgan Stanley has downgraded Lorillard (NYSE: LO) from Overweight to Equal-Weight and has established a $105 price target.

Investors looking for a defensive play, and who don't have an issue with so-called sin stocks, might be considering tobacco stocks about now. By and large, tobacco stocks continue to perform strongly, despite years of lawsuits, taxation and general disdain from the public. And some of them have the...

Bank of America has changed the price objectives on the following tobacco companies: Altria (NYSE: MO) Buy, from $27 to $30 Lorillard (NYSE: LO) Buy, from $109 to $124 Philip Morris (NYSE: PM) Buy, from $73 to $78 Reynolds American (NYSE: RAI) from $37 to $40

Deutsche Bank anticipates the upcoming crucial week for Lorillard (NYSE: LO). According to Deutsche Bank, “A critical few days ahead for menthol as TPSAC readies its report to FDA. Final TPSAC meeting March 17-18 may reveal recommendations, otherwise we look to the March 23 report date. We remain...

In a report published by Deutsche Bank, Lorillard (NYSE: LO) is bracing for impact after the TPSAC meeting. Deutsche Bank said that the second-to-last meeting focused on draft chapters & statistical model, and the process continues on a negative track. “One can argue about strength of evidence...

Deutsche Bank has published a research report on Lorillard Inc. (NYSE: LO) after the company experienced a difficult day of hearings that reaffirm the menthol risk in company products. In the report, Deutsche Bank writes "We come away slightly more concerned, and believe recommendation of menthol...

Goldman Sachs has published a research report on Lorillard, Inc. (NYSE: LO) in anticipation of the FDA Tobacco Products Scientific Advisory Committee (TPSAC) publishing of subcommittee issues in March 2011. In the report, Goldman Sachs writes "It appears increasingly unlikely that an outsized...

Lorillard Inc. (NYSE: LO) and Altria Group (NYSE: MO) have been downgraded from Buy to Hold by Stifel Nicolaus.